IEX
IDEX Corporation NYSE Listed Jun 2, 1989$214.88
Mkt Cap $15.9B
52w Low $157.25
86.5% of range
52w High $223.85
50d MA $200.02
200d MA $181.79
P/E (TTM)
33.5x
EV/EBITDA
16.2x
P/B
4.0x
Debt/Equity
0.5x
ROE
12.0%
P/FCF
21.7x
RSI (14)
—
ATR (14)
—
Beta
0.98
50d MA
$200.02
200d MA
$181.79
Avg Volume
874.2K
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.
3100 Sanders Road · Northbrook, IL 60062 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 1.78 | 2.00 | +12.4% | 217.34 | +0.9% | +0.2% | -1.3% | -0.3% | +0.7% | +1.1% | — |
| Feb 4, 2026 | TNS | 2.04 | 2.10 | +2.9% | 212.25 | -0.0% | +0.3% | -0.7% | -0.3% | +1.8% | -1.4% | — |
| Oct 29, 2025 | TNS | 1.93 | 2.03 | +5.2% | 173.40 | -0.1% | -1.8% | +0.7% | -1.9% | -0.2% | +0.2% | — |
| Jul 30, 2025 | TNS | 2.00 | 2.07 | +3.5% | 164.28 | -1.1% | -0.5% | -2.7% | -0.5% | +2.3% | -1.3% | — |
| May 1, 2025 | TNS | 1.64 | 1.75 | +6.7% | 175.25 | +2.3% | +3.5% | +0.2% | -1.2% | +0.3% | +2.5% | — |
| Feb 4, 2025 | TNS | 2.03 | 2.04 | +0.5% | 218.65 | -4.8% | -9.6% | +0.9% | -1.7% | +0.3% | -0.8% | — |
| Oct 29, 2024 | TNS | 1.89 | 1.90 | +0.5% | 203.88 | +2.8% | +7.2% | -1.8% | +0.7% | +1.4% | +2.6% | — |
| Jul 31, 2024 | TNS | 2.04 | 2.06 | +1.0% | 208.48 | -1.4% | -5.8% | -1.1% | -1.0% | -0.0% | -0.8% | — |
| Apr 23, 2024 | TNS | 1.76 | 1.88 | +6.8% | 232.27 | -0.5% | -3.3% | -0.6% | -1.2% | +1.5% | -1.5% | — |
| Feb 6, 2024 | TNS | 1.78 | 1.83 | +2.8% | 218.89 | +1.7% | +1.6% | +1.5% | +1.0% | -0.5% | -1.2% | — |
| Oct 25, 2023 | TNS | 1.89 | 2.12 | +12.2% | 187.00 | +2.2% | +3.3% | -1.2% | -0.2% | +0.5% | -1.6% | — |
| Jul 26, 2023 | TNS | 2.11 | 2.18 | +3.3% | 211.98 | -0.9% | +3.2% | +1.6% | +1.6% | -1.7% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | TD Cowen | Maintains | Buy → Buy | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.3% | -0.3% | +0.7% | +1.1% |
| Apr 30 | Citigroup | Maintains | Buy → Buy | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.3% | -0.3% | +0.7% | +1.1% |
| Apr 30 | RBC Capital | Maintains | Outperform → Outperform | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.3% | -0.3% | +0.7% | +1.1% |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $205.12 | $204.61 | -0.2% | -0.1% | -2.6% | +0.6% | +2.6% | +0.2% |
| Mar 27 | BMO Capital | Maintains | Market Perform → Market Perform | — | $189.73 | $189.42 | -0.2% | -1.7% | -1.6% | +3.3% | +1.3% | -0.8% |
| Feb 6 | Argus | Upgrade | Hold → Buy | — | $212.94 | $215.20 | +1.1% | -0.7% | -0.3% | +1.8% | -1.4% | -3.0% |
| Feb 5 | TD Cowen | Maintains | Buy → Buy | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.7% | -0.3% | +1.8% | -1.4% |
| Feb 5 | Citigroup | Maintains | Buy → Buy | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.7% | -0.3% | +1.8% | -1.4% |
| Feb 5 | RBC Capital | Maintains | Outperform → Outperform | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.7% | -0.3% | +1.8% | -1.4% |
| Feb 5 | DA Davidson | Maintains | Neutral → Neutral | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.7% | -0.3% | +1.8% | -1.4% |
| Jan 23 | Stifel | Maintains | Buy → Buy | — | $197.84 | $198.12 | +0.1% | -1.3% | -0.0% | -0.2% | +0.8% | +1.7% |
| Dec 8 | Citigroup | Maintains | Buy → Buy | — | $177.54 | $177.40 | -0.1% | -0.9% | -1.4% | +1.7% | +2.7% | -1.3% |
| Oct 30 | RBC Capital | Maintains | Outperform → Outperform | — | $173.40 | $173.31 | -0.1% | -1.8% | +0.7% | -1.9% | -0.2% | +0.2% |
| Oct 20 | Stifel | Maintains | Buy → Buy | — | $166.31 | $166.66 | +0.2% | +0.2% | +1.6% | -1.8% | +1.2% | -0.2% |
| Oct 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $167.05 | $167.31 | +0.2% | -0.7% | +0.7% | -0.6% | -2.8% | -0.2% |
| Aug 4 | DA Davidson | Maintains | Neutral → Neutral | — | $159.12 | $159.03 | -0.1% | -0.5% | +2.3% | -1.3% | -0.7% | -0.2% |
| Jul 31 | Oppenheimer | Maintains | Outperform → Outperform | — | $164.28 | $162.50 | -1.1% | -0.5% | -2.7% | -0.5% | +2.3% | -1.3% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $164.28 | $162.50 | -1.1% | -0.5% | -2.7% | -0.5% | +2.3% | -1.3% |
| Jul 31 | RBC Capital | Maintains | Outperform → Outperform | — | $164.28 | $162.50 | -1.1% | -0.5% | -2.7% | -0.5% | +2.3% | -1.3% |
| Jul 21 | Stifel | Maintains | Buy → Buy | — | $183.38 | $184.34 | +0.5% | -1.4% | +2.0% | -0.1% | -0.4% | +1.1% |
| Jul 14 | Citigroup | Maintains | Buy → Buy | — | $181.47 | $180.70 | -0.4% | -0.3% | -0.8% | +0.2% | +2.3% | -0.3% |
| May 2 | Stifel | Maintains | Buy → Buy | — | $175.25 | $179.36 | +2.3% | +3.5% | +0.2% | -1.2% | +0.3% | +2.5% |
| May 2 | RBC Capital | Maintains | Outperform → Outperform | — | $175.25 | $179.36 | +2.3% | +3.5% | +0.2% | -1.2% | +0.3% | +2.5% |
| Apr 14 | Citigroup | Maintains | Buy → Buy | — | $168.51 | $170.16 | +1.0% | +0.8% | -1.5% | -1.9% | -0.1% | -2.0% |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $168.51 | $170.16 | +1.0% | +0.8% | -1.5% | -1.9% | -0.1% | -2.0% |
| Feb 19 | DA Davidson | Maintains | Neutral → Neutral | — | $196.37 | $195.58 | -0.4% | +1.2% | -1.3% | -1.6% | +1.9% | -0.1% |
| Feb 6 | RBC Capital | Maintains | Outperform → Outperform | — | $197.58 | $198.04 | +0.2% | +0.9% | -1.7% | +0.3% | -0.8% | -0.7% |
| Jan 13 | Citigroup | Maintains | Buy → Buy | — | $206.02 | $205.09 | -0.5% | +1.9% | +2.1% | -0.0% | +1.3% | -0.7% |
| Dec 11 | Stifel | Maintains | Buy → Buy | — | $227.95 | $229.21 | +0.6% | +0.1% | -1.4% | -0.9% | +0.5% | -0.8% |
| Dec 9 | Citigroup | Maintains | Buy → Buy | — | $229.71 | $230.20 | +0.2% | -0.0% | -0.7% | +0.1% | -1.4% | -0.9% |
| Dec 6 | RBC Capital | Maintains | Outperform → Outperform | — | $228.45 | $230.12 | +0.7% | +0.6% | -0.0% | -0.7% | +0.1% | -1.4% |
| Oct 31 | RBC Capital | Maintains | Outperform → Outperform | — | $218.64 | $219.37 | +0.3% | -1.8% | +0.7% | +1.4% | +2.6% | +4.5% |
| Oct 31 | Baird | Maintains | Outperform → Outperform | — | $218.64 | $219.37 | +0.3% | -1.8% | +0.7% | +1.4% | +2.6% | +4.5% |
| Oct 16 | Stifel | Maintains | Buy → Buy | — | $211.72 | $211.81 | +0.0% | -0.5% | -0.3% | +0.3% | -0.6% | -0.7% |
| Aug 14 | Argus | Downgrade | Buy → Hold | — | $194.57 | $193.79 | -0.4% | -0.6% | +1.0% | +0.7% | +1.3% | -0.1% |
| Aug 7 | TD Cowen | Maintains | Buy → Buy | — | $192.12 | $193.61 | +0.8% | -0.8% | +2.3% | -0.3% | -1.6% | +1.7% |
| Aug 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $194.12 | $192.04 | -1.1% | -1.0% | -0.0% | -0.8% | +2.3% | -0.3% |
| Aug 5 | DA Davidson | Maintains | Neutral → Neutral | — | $194.12 | $192.04 | -1.1% | -1.0% | -0.0% | -0.8% | +2.3% | -0.3% |
| Aug 2 | RBC Capital | Maintains | Outperform → Outperform | — | $196.29 | $194.09 | -1.1% | -1.1% | -1.0% | -0.0% | -0.8% | +2.3% |
| Aug 2 | Baird | Maintains | Outperform → Outperform | — | $196.29 | $194.09 | -1.1% | -1.1% | -1.0% | -0.0% | -0.8% | +2.3% |
| Jul 18 | Stifel | Maintains | Buy → Buy | — | $210.50 | $208.78 | -0.8% | -2.0% | -1.6% | +1.1% | -0.6% | -2.5% |
| Apr 25 | Baird | Maintains | Outperform → Outperform | — | $224.64 | $223.23 | -0.6% | -0.6% | -1.2% | +1.5% | -1.5% | +0.4% |
| Apr 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $226.83 | $227.40 | +0.3% | -0.3% | +0.4% | +1.3% | +1.0% | -3.3% |
| Apr 8 | Citigroup | Maintains | Buy → Buy | — | $239.38 | $239.67 | +0.1% | -0.2% | +1.1% | -2.1% | -0.1% | -1.5% |
| Mar 21 | RBC Capital | Maintains | Outperform → Outperform | — | $240.89 | $241.12 | +0.1% | +2.1% | -0.8% | -0.8% | +0.0% | +1.2% |
| Feb 8 | Stifel | Upgrade | Hold → Buy | — | $222.42 | $225.70 | +1.5% | +1.5% | +1.0% | -0.5% | -1.2% | +1.2% |
| Feb 8 | RBC Capital | Maintains | Outperform → Outperform | — | $222.42 | $225.70 | +1.5% | +1.5% | +1.0% | -0.5% | -1.2% | +1.2% |
| Jan 23 | Stifel | Maintains | Hold → Hold | — | $207.44 | $208.59 | +0.6% | +0.9% | -1.7% | +1.0% | +0.7% | +1.4% |
| Dec 19 | Stifel | Maintains | Hold → Hold | — | $211.93 | $212.96 | +0.5% | +0.7% | -0.6% | +0.9% | +0.1% | +0.2% |
| Oct 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $196.93 | $196.98 | +0.0% | -0.7% | -1.5% | +0.1% | -0.0% | -3.0% |
No insider trades available.
8-K
IDEX Corporation -- 8-K Filing
May 8
8-K
IDEX Corporation -- 8-K Filing
IDEX Corporation exceeded first-quarter expectations driven by strong performance in Health Science Technologies growth platforms, signaling healthy demand momentum across key business divisions.
Apr 29
8-K
IDEX Corporation -- 8-K Filing
I cannot provide a meaningful investment analysis from this filing summary, as it contains only technical XBRL metadata and reference information rather than substantive corporate action or financial news.
Feb 9
8-K
IDEX Corporation -- 8-K Filing
IDEX Corporation demonstrated strong platform growth execution in 2025, with CEO Eric Ashleman highlighting positive results from the company's strategic initiatives across global operations.
Feb 4
Data updated apr 25, 2026 3:02pm
· Source: massive.com